JC BioSciences is a consumer health and early-stage drug development company specializing in products for the mitigation and prevention of biological senescence, treatment of age-related diseases, non-opioid pain reduction, and the extension of health span in humans and animals.
JC BioSciences operates on a virtual research enterprise model, employing specialized research scientists across the world. The company currently has about a dozen research associates, including PhDs and MDs with degrees in biochemistry, theoretical chemistry, statistics, pharmacology, and medicine. Since innovative product discoveries are often the result of a convergence between seemingly unrelated research, maintaining a broad base of specialists across a number of emerging areas of medical research is a key to our success.